nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Alopecia reversible—Mesalazine—Crohn's disease	0.0449	0.0538	CcSEcCtD
Acebutolol—Lupus-like syndrome—Mesalazine—Crohn's disease	0.0433	0.0519	CcSEcCtD
Acebutolol—Ache—Mesalazine—Crohn's disease	0.0221	0.0265	CcSEcCtD
Acebutolol—Lung infiltration—Mesalazine—Crohn's disease	0.0217	0.0261	CcSEcCtD
Acebutolol—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.0186	0.112	CbGpPWpGaD
Acebutolol—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.0186	0.112	CbGpPWpGaD
Acebutolol—Systemic lupus erythematosus—Mesalazine—Crohn's disease	0.0184	0.0221	CcSEcCtD
Acebutolol—ADRB2—Arf6 trafficking events—VAMP3—Crohn's disease	0.0147	0.0885	CbGpPWpGaD
Acebutolol—Throat sore—Mesalazine—Crohn's disease	0.0141	0.017	CcSEcCtD
Acebutolol—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.014	0.0168	CcSEcCtD
Acebutolol—Rash erythematous—Mesalazine—Crohn's disease	0.0133	0.016	CcSEcCtD
Acebutolol—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0126	0.076	CbGpPWpGaD
Acebutolol—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0126	0.076	CbGpPWpGaD
Acebutolol—Oropharyngeal pain—Mesalazine—Crohn's disease	0.0112	0.0134	CcSEcCtD
Acebutolol—Blood bilirubin increased—Mesalazine—Crohn's disease	0.0108	0.0129	CcSEcCtD
Acebutolol—Abnormal dreams—Mesalazine—Crohn's disease	0.0101	0.0121	CcSEcCtD
Acebutolol—Dry eye—Mesalazine—Crohn's disease	0.00942	0.0113	CcSEcCtD
Acebutolol—Alopecia—Mercaptopurine—Crohn's disease	0.00834	0.00999	CcSEcCtD
Acebutolol—Disorientation—Mesalazine—Crohn's disease	0.00827	0.00992	CcSEcCtD
Acebutolol—Eye pain—Mesalazine—Crohn's disease	0.0082	0.00982	CcSEcCtD
Acebutolol—Lethargy—Mesalazine—Crohn's disease	0.00755	0.00905	CcSEcCtD
Acebutolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00754	0.0455	CbGpPWpGaD
Acebutolol—Affect lability—Mesalazine—Crohn's disease	0.00728	0.00873	CcSEcCtD
Acebutolol—Mood swings—Mesalazine—Crohn's disease	0.00701	0.0084	CcSEcCtD
Acebutolol—Arthralgia—Mercaptopurine—Crohn's disease	0.00699	0.00838	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00694	0.00832	CcSEcCtD
Acebutolol—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00676	0.0081	CcSEcCtD
Acebutolol—Oedema—Mercaptopurine—Crohn's disease	0.0067	0.00803	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00666	0.00799	CcSEcCtD
Acebutolol—Skin disorder—Mercaptopurine—Crohn's disease	0.00651	0.0078	CcSEcCtD
Acebutolol—Anorexia—Mercaptopurine—Crohn's disease	0.00639	0.00766	CcSEcCtD
Acebutolol—Pneumonia—Azathioprine—Crohn's disease	0.0063	0.00755	CcSEcCtD
Acebutolol—Bronchospasm—Mesalazine—Crohn's disease	0.00629	0.00754	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00611	0.00732	CcSEcCtD
Acebutolol—Dysuria—Mesalazine—Crohn's disease	0.00598	0.00717	CcSEcCtD
Acebutolol—Agranulocytosis—Azathioprine—Crohn's disease	0.00584	0.007	CcSEcCtD
Acebutolol—Decreased appetite—Mercaptopurine—Crohn's disease	0.00583	0.00698	CcSEcCtD
Acebutolol—Weight increased—Mesalazine—Crohn's disease	0.00582	0.00698	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00579	0.00693	CcSEcCtD
Acebutolol—Pneumonia—Mesalazine—Crohn's disease	0.00574	0.00688	CcSEcCtD
Acebutolol—Depression—Mesalazine—Crohn's disease	0.00569	0.00682	CcSEcCtD
Acebutolol—Conjunctivitis—Mesalazine—Crohn's disease	0.00554	0.00664	CcSEcCtD
Acebutolol—Sweating—Mesalazine—Crohn's disease	0.00547	0.00655	CcSEcCtD
Acebutolol—Agranulocytosis—Mesalazine—Crohn's disease	0.00532	0.00638	CcSEcCtD
Acebutolol—Body temperature increased—Mercaptopurine—Crohn's disease	0.0053	0.00635	CcSEcCtD
Acebutolol—Rhinitis—Mesalazine—Crohn's disease	0.00513	0.00615	CcSEcCtD
Acebutolol—Pharyngitis—Mesalazine—Crohn's disease	0.00508	0.00609	CcSEcCtD
Acebutolol—Mediastinal disorder—Azathioprine—Crohn's disease	0.00507	0.00607	CcSEcCtD
Acebutolol—Chills—Azathioprine—Crohn's disease	0.00504	0.00604	CcSEcCtD
Acebutolol—Connective tissue disorder—Mesalazine—Crohn's disease	0.00503	0.00603	CcSEcCtD
Acebutolol—Alopecia—Azathioprine—Crohn's disease	0.00497	0.00595	CcSEcCtD
Acebutolol—Tinnitus—Mesalazine—Crohn's disease	0.00477	0.00572	CcSEcCtD
Acebutolol—Angiopathy—Mesalazine—Crohn's disease	0.00464	0.00557	CcSEcCtD
Acebutolol—Mediastinal disorder—Mesalazine—Crohn's disease	0.00461	0.00553	CcSEcCtD
Acebutolol—Chills—Mesalazine—Crohn's disease	0.00459	0.00551	CcSEcCtD
Acebutolol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00459	0.0055	CcSEcCtD
Acebutolol—Ill-defined disorder—Azathioprine—Crohn's disease	0.00454	0.00544	CcSEcCtD
Acebutolol—Alopecia—Mesalazine—Crohn's disease	0.00452	0.00542	CcSEcCtD
Acebutolol—Malaise—Azathioprine—Crohn's disease	0.00441	0.00529	CcSEcCtD
Acebutolol—Flatulence—Mesalazine—Crohn's disease	0.00439	0.00526	CcSEcCtD
Acebutolol—Cardiac failure congestive—Prednisone—Crohn's disease	0.00432	0.00517	CcSEcCtD
Acebutolol—Back pain—Mesalazine—Crohn's disease	0.00431	0.00517	CcSEcCtD
Acebutolol—Vomiting—Mercaptopurine—Crohn's disease	0.00426	0.00511	CcSEcCtD
Acebutolol—Rash—Mercaptopurine—Crohn's disease	0.00423	0.00506	CcSEcCtD
Acebutolol—Dermatitis—Mercaptopurine—Crohn's disease	0.00422	0.00506	CcSEcCtD
Acebutolol—Vision blurred—Mesalazine—Crohn's disease	0.0042	0.00503	CcSEcCtD
Acebutolol—Amnesia—Prednisone—Crohn's disease	0.00417	0.00499	CcSEcCtD
Acebutolol—Arthralgia—Azathioprine—Crohn's disease	0.00417	0.00499	CcSEcCtD
Acebutolol—Myalgia—Azathioprine—Crohn's disease	0.00417	0.00499	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00414	0.00496	CcSEcCtD
Acebutolol—Ill-defined disorder—Mesalazine—Crohn's disease	0.00414	0.00496	CcSEcCtD
Acebutolol—Discomfort—Azathioprine—Crohn's disease	0.00412	0.00493	CcSEcCtD
Acebutolol—Malaise—Mesalazine—Crohn's disease	0.00402	0.00482	CcSEcCtD
Acebutolol—Cardiac failure—Prednisone—Crohn's disease	0.00401	0.00481	CcSEcCtD
Acebutolol—Vertigo—Mesalazine—Crohn's disease	0.004	0.0048	CcSEcCtD
Acebutolol—Syncope—Mesalazine—Crohn's disease	0.004	0.00479	CcSEcCtD
Acebutolol—Lethargy—Prednisone—Crohn's disease	0.004	0.00479	CcSEcCtD
Acebutolol—Nausea—Mercaptopurine—Crohn's disease	0.00398	0.00477	CcSEcCtD
Acebutolol—Palpitations—Mesalazine—Crohn's disease	0.00394	0.00472	CcSEcCtD
Acebutolol—Loss of consciousness—Mesalazine—Crohn's disease	0.00392	0.00469	CcSEcCtD
Acebutolol—Cough—Mesalazine—Crohn's disease	0.00389	0.00466	CcSEcCtD
Acebutolol—Skin disorder—Azathioprine—Crohn's disease	0.00388	0.00465	CcSEcCtD
Acebutolol—Affect lability—Prednisone—Crohn's disease	0.00385	0.00462	CcSEcCtD
Acebutolol—Psychotic disorder—Prednisone—Crohn's disease	0.00382	0.00458	CcSEcCtD
Acebutolol—Myalgia—Mesalazine—Crohn's disease	0.00379	0.00455	CcSEcCtD
Acebutolol—Arthralgia—Mesalazine—Crohn's disease	0.00379	0.00455	CcSEcCtD
Acebutolol—Chest pain—Mesalazine—Crohn's disease	0.00379	0.00455	CcSEcCtD
Acebutolol—Anxiety—Mesalazine—Crohn's disease	0.00378	0.00453	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00377	0.00452	CcSEcCtD
Acebutolol—Discomfort—Mesalazine—Crohn's disease	0.00375	0.00449	CcSEcCtD
Acebutolol—Hypotension—Azathioprine—Crohn's disease	0.00373	0.00447	CcSEcCtD
Acebutolol—Mood swings—Prednisone—Crohn's disease	0.00371	0.00445	CcSEcCtD
Acebutolol—Confusional state—Mesalazine—Crohn's disease	0.00367	0.0044	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00364	0.00436	CcSEcCtD
Acebutolol—Oedema—Mesalazine—Crohn's disease	0.00364	0.00436	CcSEcCtD
Acebutolol—Shock—Mesalazine—Crohn's disease	0.00358	0.00429	CcSEcCtD
Acebutolol—Nervous system disorder—Mesalazine—Crohn's disease	0.00357	0.00428	CcSEcCtD
Acebutolol—Skin disorder—Mesalazine—Crohn's disease	0.00353	0.00423	CcSEcCtD
Acebutolol—Hyperhidrosis—Mesalazine—Crohn's disease	0.00352	0.00421	CcSEcCtD
Acebutolol—Anorexia—Mesalazine—Crohn's disease	0.00347	0.00416	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00345	0.00413	CcSEcCtD
Acebutolol—Hypotension—Mesalazine—Crohn's disease	0.0034	0.00407	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00331	0.00397	CcSEcCtD
Acebutolol—Feeling abnormal—Azathioprine—Crohn's disease	0.00329	0.00394	CcSEcCtD
Acebutolol—Insomnia—Mesalazine—Crohn's disease	0.00329	0.00394	CcSEcCtD
Acebutolol—Paraesthesia—Mesalazine—Crohn's disease	0.00327	0.00391	CcSEcCtD
Acebutolol—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00327	0.00391	CcSEcCtD
Acebutolol—Dyspnoea—Mesalazine—Crohn's disease	0.00324	0.00389	CcSEcCtD
Acebutolol—Somnolence—Mesalazine—Crohn's disease	0.00323	0.00388	CcSEcCtD
Acebutolol—Dyspepsia—Mesalazine—Crohn's disease	0.0032	0.00384	CcSEcCtD
Acebutolol—Decreased appetite—Mesalazine—Crohn's disease	0.00316	0.00379	CcSEcCtD
Acebutolol—Abdominal pain—Azathioprine—Crohn's disease	0.00316	0.00378	CcSEcCtD
Acebutolol—Body temperature increased—Azathioprine—Crohn's disease	0.00316	0.00378	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00314	0.00376	CcSEcCtD
Acebutolol—Fatigue—Mesalazine—Crohn's disease	0.00314	0.00376	CcSEcCtD
Acebutolol—Erectile dysfunction—Prednisone—Crohn's disease	0.00312	0.00374	CcSEcCtD
Acebutolol—Pain—Mesalazine—Crohn's disease	0.00311	0.00373	CcSEcCtD
Acebutolol—Constipation—Mesalazine—Crohn's disease	0.00311	0.00373	CcSEcCtD
Acebutolol—Weight increased—Prednisone—Crohn's disease	0.00308	0.00369	CcSEcCtD
Acebutolol—Depression—Prednisone—Crohn's disease	0.00301	0.00361	CcSEcCtD
Acebutolol—Feeling abnormal—Mesalazine—Crohn's disease	0.003	0.00359	CcSEcCtD
Acebutolol—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00297	0.00356	CcSEcCtD
Acebutolol—Urticaria—Mesalazine—Crohn's disease	0.00289	0.00346	CcSEcCtD
Acebutolol—Abdominal pain—Mesalazine—Crohn's disease	0.00288	0.00345	CcSEcCtD
Acebutolol—Body temperature increased—Mesalazine—Crohn's disease	0.00288	0.00345	CcSEcCtD
Acebutolol—Bradycardia—Prednisone—Crohn's disease	0.00276	0.00331	CcSEcCtD
Acebutolol—Diarrhoea—Azathioprine—Crohn's disease	0.00273	0.00327	CcSEcCtD
Acebutolol—Hallucination—Prednisone—Crohn's disease	0.0027	0.00323	CcSEcCtD
Acebutolol—Connective tissue disorder—Prednisone—Crohn's disease	0.00266	0.00319	CcSEcCtD
Acebutolol—Dizziness—Azathioprine—Crohn's disease	0.00264	0.00316	CcSEcCtD
Acebutolol—Asthenia—Mesalazine—Crohn's disease	0.00261	0.00313	CcSEcCtD
Acebutolol—Pruritus—Mesalazine—Crohn's disease	0.00257	0.00308	CcSEcCtD
Acebutolol—Vomiting—Azathioprine—Crohn's disease	0.00254	0.00304	CcSEcCtD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00252	0.0152	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00252	0.0152	CbGpPWpGaD
Acebutolol—Rash—Azathioprine—Crohn's disease	0.00252	0.00302	CcSEcCtD
Acebutolol—Dermatitis—Azathioprine—Crohn's disease	0.00252	0.00301	CcSEcCtD
Acebutolol—Flushing—Prednisone—Crohn's disease	0.00251	0.00301	CcSEcCtD
Acebutolol—Headache—Azathioprine—Crohn's disease	0.0025	0.003	CcSEcCtD
Acebutolol—Diarrhoea—Mesalazine—Crohn's disease	0.00249	0.00298	CcSEcCtD
Acebutolol—Angiopathy—Prednisone—Crohn's disease	0.00246	0.00295	CcSEcCtD
Acebutolol—Dizziness—Mesalazine—Crohn's disease	0.00241	0.00288	CcSEcCtD
Acebutolol—Alopecia—Prednisone—Crohn's disease	0.00239	0.00287	CcSEcCtD
Acebutolol—Nausea—Azathioprine—Crohn's disease	0.00237	0.00284	CcSEcCtD
Acebutolol—Vomiting—Mesalazine—Crohn's disease	0.00231	0.00277	CcSEcCtD
Acebutolol—Rash—Mesalazine—Crohn's disease	0.00229	0.00275	CcSEcCtD
Acebutolol—Dermatitis—Mesalazine—Crohn's disease	0.00229	0.00275	CcSEcCtD
Acebutolol—Headache—Mesalazine—Crohn's disease	0.00228	0.00273	CcSEcCtD
Acebutolol—ADRB2—Arf6 trafficking events—ITGA4—Crohn's disease	0.00225	0.0136	CbGpPWpGaD
Acebutolol—Vision blurred—Prednisone—Crohn's disease	0.00222	0.00266	CcSEcCtD
Acebutolol—Ill-defined disorder—Prednisone—Crohn's disease	0.00219	0.00262	CcSEcCtD
Acebutolol—Nausea—Mesalazine—Crohn's disease	0.00216	0.00259	CcSEcCtD
Acebutolol—Malaise—Prednisone—Crohn's disease	0.00213	0.00255	CcSEcCtD
Acebutolol—Vertigo—Prednisone—Crohn's disease	0.00212	0.00254	CcSEcCtD
Acebutolol—Syncope—Prednisone—Crohn's disease	0.00211	0.00253	CcSEcCtD
Acebutolol—Loss of consciousness—Prednisone—Crohn's disease	0.00207	0.00248	CcSEcCtD
Acebutolol—Myalgia—Prednisone—Crohn's disease	0.00201	0.00241	CcSEcCtD
Acebutolol—Arthralgia—Prednisone—Crohn's disease	0.00201	0.00241	CcSEcCtD
Acebutolol—Anxiety—Prednisone—Crohn's disease	0.002	0.0024	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00199	0.00239	CcSEcCtD
Acebutolol—Discomfort—Prednisone—Crohn's disease	0.00198	0.00238	CcSEcCtD
Acebutolol—Oedema—Prednisone—Crohn's disease	0.00192	0.00231	CcSEcCtD
Acebutolol—Shock—Prednisone—Crohn's disease	0.00189	0.00227	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—Crohn's disease	0.00189	0.00226	CcSEcCtD
Acebutolol—Skin disorder—Prednisone—Crohn's disease	0.00187	0.00224	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—Crohn's disease	0.00186	0.00223	CcSEcCtD
Acebutolol—Anorexia—Prednisone—Crohn's disease	0.00183	0.0022	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00176	0.0106	CbGpPWpGaD
Acebutolol—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00175	0.0021	CcSEcCtD
Acebutolol—Insomnia—Prednisone—Crohn's disease	0.00174	0.00209	CcSEcCtD
Acebutolol—Paraesthesia—Prednisone—Crohn's disease	0.00173	0.00207	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00172	0.0104	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.0017	0.0102	CbGpPWpGaD
Acebutolol—Dyspepsia—Prednisone—Crohn's disease	0.00169	0.00203	CcSEcCtD
Acebutolol—Decreased appetite—Prednisone—Crohn's disease	0.00167	0.00201	CcSEcCtD
Acebutolol—Fatigue—Prednisone—Crohn's disease	0.00166	0.00199	CcSEcCtD
Acebutolol—Constipation—Prednisone—Crohn's disease	0.00165	0.00197	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisone—Crohn's disease	0.00159	0.0019	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—Crohn's disease	0.00157	0.00189	CcSEcCtD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00157	0.00948	CbGpPWpGaD
Acebutolol—Urticaria—Prednisone—Crohn's disease	0.00153	0.00183	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—Crohn's disease	0.00152	0.00182	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—Crohn's disease	0.00152	0.00182	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00151	0.00912	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00148	0.00892	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00143	0.00864	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0014	0.00846	CbGpPWpGaD
Acebutolol—Asthenia—Prednisone—Crohn's disease	0.00138	0.00165	CcSEcCtD
Acebutolol—Pruritus—Prednisone—Crohn's disease	0.00136	0.00163	CcSEcCtD
Acebutolol—Diarrhoea—Prednisone—Crohn's disease	0.00132	0.00158	CcSEcCtD
Acebutolol—Dizziness—Prednisone—Crohn's disease	0.00127	0.00153	CcSEcCtD
Acebutolol—Vomiting—Prednisone—Crohn's disease	0.00122	0.00147	CcSEcCtD
Acebutolol—ADRB1—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00121	0.00733	CbGpPWpGaD
Acebutolol—Rash—Prednisone—Crohn's disease	0.00121	0.00145	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—Crohn's disease	0.00121	0.00145	CcSEcCtD
Acebutolol—Headache—Prednisone—Crohn's disease	0.00121	0.00144	CcSEcCtD
Acebutolol—ADRB2—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00119	0.00717	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00116	0.00699	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—ACKR2—Crohn's disease	0.00115	0.00694	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00115	0.00692	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00115	0.00692	CbGpPWpGaD
Acebutolol—Nausea—Prednisone—Crohn's disease	0.00114	0.00137	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00113	0.00684	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.00113	0.00679	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—MLN—Crohn's disease	0.00109	0.00658	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00108	0.0065	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—MLN—Crohn's disease	0.00107	0.00644	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00105	0.00636	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000993	0.00599	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000971	0.00586	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00094	0.00567	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000923	0.00557	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000903	0.00545	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000892	0.00538	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000829	0.005	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000807	0.00487	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000767	0.00463	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCR9—Crohn's disease	0.000756	0.00456	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000751	0.00453	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.000739	0.00446	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000714	0.00431	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GPR65—Crohn's disease	0.000703	0.00424	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.000687	0.00415	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000676	0.00408	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000674	0.00407	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000661	0.00399	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000657	0.00397	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000643	0.00388	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000634	0.00382	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.000616	0.00372	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000606	0.00366	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.000603	0.00364	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.00059	0.00356	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000582	0.00351	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000582	0.00351	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000579	0.00349	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.000577	0.00349	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000566	0.00342	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.00056	0.00338	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.000547	0.0033	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.00054	0.00326	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.000501	0.00302	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.00049	0.00296	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.000441	0.00266	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.000431	0.0026	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.000427	0.00258	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.000418	0.00252	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00041	0.00248	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.000397	0.0024	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.000388	0.00234	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.000388	0.00234	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000381	0.0023	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.000379	0.00229	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000363	0.00219	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	0.000361	0.00218	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000356	0.00215	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.000353	0.00213	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	0.000349	0.0021	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000341	0.00206	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000341	0.00206	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.000341	0.00206	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000331	0.002	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MLN—Crohn's disease	0.000331	0.002	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.000323	0.00195	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	0.000321	0.00194	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000318	0.00192	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	0.000302	0.00183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.000296	0.00179	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	0.000283	0.00171	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.000277	0.00167	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTMR3—Crohn's disease	0.000273	0.00165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	0.000264	0.0016	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.000259	0.00156	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	0.000257	0.00155	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000257	0.00155	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.000251	0.00152	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	0.000251	0.00151	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000249	0.0015	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.000245	0.00148	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000244	0.00147	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00024	0.00145	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000231	0.00139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	0.000229	0.00138	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	0.000226	0.00137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.000224	0.00135	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.000221	0.00134	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	0.000213	0.00129	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000213	0.00128	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—FADS1—Crohn's disease	0.000212	0.00128	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	0.000212	0.00128	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000212	0.00128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.000208	0.00126	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.000208	0.00125	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000207	0.00125	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000205	0.00124	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000201	0.00121	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX4—Crohn's disease	0.000199	0.0012	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	0.000193	0.00116	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GCKR—Crohn's disease	0.000192	0.00116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.000188	0.00114	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000188	0.00113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000186	0.00112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000182	0.0011	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000177	0.00107	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000169	0.00102	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	0.000161	0.000974	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTMR3—Crohn's disease	0.00016	0.000965	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.000158	0.000953	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	0.000152	0.000916	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000151	0.000909	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000149	0.000897	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.000148	0.000896	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000145	0.000878	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	0.000137	0.000829	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	0.000135	0.000815	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.000134	0.000811	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	0.000134	0.000807	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.000132	0.000797	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000131	0.000789	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000131	0.000788	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—FADS1—Crohn's disease	0.000125	0.000752	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	0.00012	0.000727	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000118	0.000711	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000117	0.000708	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	0.000117	0.000705	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX4—Crohn's disease	0.000117	0.000704	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	0.000114	0.000689	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000114	0.000687	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL3—Crohn's disease	0.000114	0.000687	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCKR—Crohn's disease	0.000113	0.00068	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL3—Crohn's disease	0.000111	0.000672	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	0.00011	0.000665	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX4—Crohn's disease	0.00011	0.000663	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000108	0.00065	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000106	0.000641	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	9.99e-05	0.000603	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	9.97e-05	0.000602	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	9.77e-05	0.00059	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	9.76e-05	0.000589	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	9.51e-05	0.000574	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	9.3e-05	0.000562	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	9.12e-05	0.00055	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	9.07e-05	0.000548	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	8.92e-05	0.000538	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	8.87e-05	0.000536	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	8.61e-05	0.00052	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	8.42e-05	0.000508	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	8.28e-05	0.0005	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	8.1e-05	0.000489	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	7.97e-05	0.000481	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	7.8e-05	0.000471	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.65e-05	0.000462	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—Crohn's disease	6.11e-05	0.000369	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	5.62e-05	0.000339	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	5.5e-05	0.000332	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	5.36e-05	0.000323	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—Crohn's disease	5.35e-05	0.000323	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	5.24e-05	0.000316	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	4.89e-05	0.000295	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	4.78e-05	0.000289	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	4.65e-05	0.000281	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	4.55e-05	0.000275	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	3.93e-05	0.000237	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	3.85e-05	0.000232	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—Crohn's disease	3.58e-05	0.000216	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—Crohn's disease	3.38e-05	0.000204	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—Crohn's disease	3.14e-05	0.000189	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.95e-05	0.000178	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—Crohn's disease	2.75e-05	0.000166	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—Crohn's disease	2.69e-05	0.000162	CbGpPWpGaD
